Cannabis Conundrum

Cardiovascular Effects of Marijuana & Synthetic Cannabinoids

Key points Activation of cannabinoid receptor 1 (CB1R) by endocannabinoids or synthetic ligands mediates acute haemodynamic effects and might contribute to pathology in cardiovascular disease; activation of cannabinoid receptor 2 (CB2R) exerts anti-inflammatory effects The psychoactive constituent of marijuana, Δ9‑tetrahydrocannabinol (THC), exerts its cardiovascular effects via CB1R activation; at low doses it might have beneficial

Cardiovascular Effects of Marijuana & Synthetic Cannabinoids Read More »

Sedation and Acute Encephalopathy in a Paediatric Patient Following Ingestion of Delta-8-Tetrahydrocannabinol Gummies

Children eating the grown-ups ‘medicinal marijuana’ Gummy Bears, being not only sedated but experiencing a disease that affects brain structure and/or function. Encephalopathy causes altered mental state and confusion – Welcome to THC – and its analogues – use! Sedation and Acute Encephalopathy in a Paediatric Patient Following Ingestion of Delta-8-Tetrahydrocannabinol Gummies Abstract BACKGROUND Delta-8

Sedation and Acute Encephalopathy in a Paediatric Patient Following Ingestion of Delta-8-Tetrahydrocannabinol Gummies Read More »

Cannabis and Psychosis Through the Lens of DSM-5

DOI: 10.3390/ijerph16214149 Abstract: Evidence for an association between cannabis and psychosis has been documented in literature in many forms including experimental studies, epidemiological data, and case series. The association has implications for psychotic outcomes ranging from mild to severe and occurring over minutes to years. Due to the huge variety of exposures and outcome measures reported,

Cannabis and Psychosis Through the Lens of DSM-5 Read More »

United States marijuana legalization and opioid mortality epidemic during 2010–2020 and pandemic implications

Author links open overlay panel. https://doi.org/10.1016/j.jnma.2022.03.004Get rights and content Highlights Many states and District of Columbia in the United States have legalized marijuana. One reason is to expect marijuana to help reduce opioid dependence and mortality. However, opioid deaths have increased more where marijuana was legalized. This correlation is highly statistically significant for all opioids and fentanyl subgroup. The

United States marijuana legalization and opioid mortality epidemic during 2010–2020 and pandemic implications Read More »

Cannabis Ages You – and Fast! Lifetime marijuana use and epigenetic age acceleration: A 17-year prospective examination 

Abstract – Aims: This study was designed to assess links between lifetime levels of marijuana use and accelerated epigenetic aging. Design: Prospective longitudinal study, following participants annually from age 13 to age 30. Findings: Lifetime marijuana use predicted accelerated epigenetic aging, with effects remaining even after covarying cell counts, demographic factors and chronological age (β’s = 0.32 &

Cannabis Ages You – and Fast! Lifetime marijuana use and epigenetic age acceleration: A 17-year prospective examination  Read More »

Cannabis Causing Cancer

Cannabis Causing Cancer Part 1 – Epidemiological overview and survey of USA cannabis, cannabidiol and cannabinoid genotoxicity expressed in cancer incidence 2003–2017: Part 1: Complete Research here https://rdcu.be/cKfKp Conclusion: Data suggest that cannabinoids including THC and cannabidiol are important community carcinogens exceeding the effects of tobacco or alcohol. Testicular, (prostatic) and ovarian tumours indicate mutagenic

Cannabis Causing Cancer Read More »

Effect of Marijuana on Brain Health

(Published in Neurology) TAKE-HOME MESSAGE In this AHA Scientific Statement, numerous effects of marijuana on brain health are described. These include the effects of: 1) prenatal cannabinoid exposure as well as abnormal fetal neurotransmission in preclinical models and its impact on neuroanatomic areas associated with cognition and emotional regulation; 2) marijuana use on human cognition focusing on possible structural

Effect of Marijuana on Brain Health Read More »

Marijuana & Aging – The Epigenetic Impact (2022)

Aims: This study was designed to assess links between lifetime levels of marijuana use and accelerated epigenetic aging. Design: Prospective longitudinal study, following participants annually from age 13 to age 30. Setting and participants: A community sample of 154 participants recruited from a small city in the Southeastern United States. Measurements: Participants completed annual assessments

Marijuana & Aging – The Epigenetic Impact (2022) Read More »

Scroll to Top